IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2022i1p457-d1016898.html
   My bibliography  Save this article

Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review

Author

Listed:
  • Hani Serag

    (Department of International Medicine, School of Medicine, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA)

  • Isabel Clark

    (HIV/STD Prevention & Care Unit, Texas Department of State Health Services, Austin, TX 78714, USA)

  • Cherith Naig

    (MPH Program, School of Public and Population Health, University of Texas Medical Branch (UTMB), Galveston, TX 77555, USA)

  • David Lakey

    (Administration Division, University of Texas System, Austin, TX 78701, USA)

  • Yordanos M. Tiruneh

    (Department of Preventive Medicine and Population Health, School of Medicine, University of Texas Tyler, Tyler, TX 75799, USA
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA)

Abstract

The Centers for Disease Control and Prevention recommends everyone between 13–64 years be tested for HIV at least once as a routine procedure. Routine HIV screening is reimbursable by Medicare, Medicaid, expanded Medicaid, and most commercial insurance plans. Yet, scaling-up HIV routine screening remains a challenge. We conducted a scoping review for studies on financial benefits and barriers associated with HIV screening in clinical settings in the U.S. to inform an evidence-based strategy to scale-up routine HIV screening. We searched Ovid MEDLINE ® , Cochrane, and Scopus for studies published between 2006–2020 in English. The search identified 383 Citations; we screened 220 and excluded 163 (outside the time limit, irrelevant, or outside the U.S.). Of the 220 screened articles, we included 35 and disqualified 155 (did not meet the eligibility criteria). We organized eligible articles under two themes: financial benefits/barriers of routine HIV screening in healthcare settings (9 articles); and Cost-effectiveness of routine screening in healthcare settings (26 articles). The review concluded drawing recommendations in three areas: (1) Finance: Incentivize healthcare providers/systems for implementing HIV routine screening and/or separate its reimbursement from bundle payments; (2) Personnel: Encourage nurse-initiated HIV screening programs in primary care settings and educate providers on CDC recommendations; and (3) Approach: Use opt-out approach.

Suggested Citation

  • Hani Serag & Isabel Clark & Cherith Naig & David Lakey & Yordanos M. Tiruneh, 2022. "Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review," IJERPH, MDPI, vol. 20(1), pages 1-13, December.
  • Handle: RePEc:gam:jijerp:v:20:y:2022:i:1:p:457-:d:1016898
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/1/457/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/20/1/457/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Obermeyer, C.M. & Osborn, M., 2007. "The utilization of testing and counseling for HIV: A review of the social and behavioral evidence," American Journal of Public Health, American Public Health Association, vol. 97(10), pages 1762-1774.
    2. Lauren E Cipriano & Gregory S Zaric & Mark Holodniy & Eran Bendavid & Douglas K Owens & Margaret L Brandeau, 2012. "Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-14, September.
    3. Angela B Hutchinson & Pragna Patel & Stephanie L Sansom & Paul G Farnham & Timothy J Sullivan & Berry Bennett & Peter R Kerndt & Robert K Bolan & James D Heffelfinger & Vimalanand S Prabhu & Bernard M, 2010. "Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Publ," PLOS Medicine, Public Library of Science, vol. 7(9), pages 1-10, September.
    4. Hoenigl, Martin & Graff-Zivin, Joshua & Little, Susan J, 2016. "Costs per Diagnosis of Acute HIV Infection in Community-based Screening Strategies: A Comparative Analysis of Four Screening Algorithms," University of California at San Diego, Economics Working Paper Series qt9zp2x018, Department of Economics, UC San Diego.
    5. Owens, D.K. & Sundaram, V. & Lazzeroni, L.C. & Douglass, L.R. & Sanders, G.D. & Taylor, K. & VanGroningen, R. & Shadle, V.M. & McWhorter, V.C. & Agoncillo, T. & Haren, N. & Nyland, J. & Tempio, P. & K, 2007. "Prevalence of HIV infection among inpatients and outpatients in department of veterans affairs health care systems: Implications for screening programs for HIV," American Journal of Public Health, American Public Health Association, vol. 97(12), pages 2173-2178.
    6. Fabrizio Bert & Maria Rosaria Gualano & Paolo Biancone & Valerio Brescia & Elisa Camussi & Maria Martorana & Robin Thomas & Silvana Secinaro & Roberta Siliquini, 2018. "HIV screening in pregnant women: A systematic review of cost‐effectiveness studies," International Journal of Health Planning and Management, Wiley Blackwell, vol. 33(1), pages 31-50, January.
    7. Brett Saraniti, 2006. "Optimal pooled testing," Health Care Management Science, Springer, vol. 9(2), pages 143-149, May.
    8. Elisa F Long, 2011. "HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-10, November.
    9. Everistus Ibekwe & Carol Haigh & Fiona Duncan & Francis Fatoye, 2017. "Economic impact of routine opt‐out antenatal human immune deficiency virus screening: A systematic review," Journal of Clinical Nursing, John Wiley & Sons, vol. 26(23-24), pages 3832-3842, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bert, Fabrizio & Gualano, Maria Rosaria & Biancone, Paolo & Brescia, Valerio & Camussi, Elisa & Martorana, Maria & Secinaro, Silvana & Siliquini, Roberta, 2018. "Cost-effectiveness of HIV screening in high-income countries: A systematic review," Health Policy, Elsevier, vol. 122(5), pages 533-547.
    2. Kévin Jean & Xavier Anglaret & Raoul Moh & France Lert & Rosemary Dray-Spira, 2012. "Barriers to HIV Testing in Côte d'Ivoire: The Role of Individual Characteristics and Testing Modalities," PLOS ONE, Public Library of Science, vol. 7(7), pages 1-9, July.
    3. Steward, Wayne T. & Herek, Gregory M. & Ramakrishna, Jayashree & Bharat, Shalini & Chandy, Sara & Wrubel, Judith & Ekstrand, Maria L., 2008. "HIV-related stigma: Adapting a theoretical framework for use in India," Social Science & Medicine, Elsevier, vol. 67(8), pages 1225-1235, October.
    4. Yohannes Ejigu & Biniyam Tadesse, 2018. "HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-11, August.
    5. Olanrewaju Medu & Adegboyega Lawal & Doug Coyle & Kevin Pottie, 2021. "Economic evaluation of HIV testing options for low-prevalence high-income countries: a systematic review," Health Economics Review, Springer, vol. 11(1), pages 1-11, December.
    6. Boyd, Donte & Lea, Charles H. & Gilbert, Keon L. & Butler-Barnes, Sheretta T., 2018. "Sexual health conversations: Predicting the odds of HIV testing among black youth and young adults," Children and Youth Services Review, Elsevier, vol. 90(C), pages 134-140.
    7. Inghels, Maxime & Kim, Hae-Young & Mathenjwa, Thulile & Shahmanesh, Maryam & Seeley, Janet & Wyke, Sally & McGrath, Nuala & Sartorius, Benn & Yapa, H. Manisha & Dobra, Adrian & Bärnighausen, Till & Ta, 2022. "Can a conditional financial incentive (CFI) reduce socio-demographic inequalities in home-based HIV testing uptake? A secondary analysis of the HITS clinical trial intervention in rural South Africa," Social Science & Medicine, Elsevier, vol. 311(C).
    8. Hrayer Aprahamian & Douglas R. Bish & Ebru K. Bish, 2020. "Optimal Group Testing: Structural Properties and Robust Solutions, with Application to Public Health Screening," INFORMS Journal on Computing, INFORMS, vol. 32(4), pages 895-911, October.
    9. Hrayer Aprahamian & Hadi El-Amine, 2022. "Optimal Screening of Populations with Heterogeneous Risk Profiles Under the Availability of Multiple Tests," INFORMS Journal on Computing, INFORMS, vol. 34(1), pages 150-164, January.
    10. Black, Samantha & Wallace, Melissa & Middelkoop, Keren & Robbertze, Dante & Bennie, Thola & Wood, Robin & Bekker, Linda-Gail, 2014. "Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program: Insights from South Africa," Children and Youth Services Review, Elsevier, vol. 45(C), pages 98-105.
    11. Elisa F Long, 2011. "HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-10, November.
    12. Deblonde, Jessika & Meulemans, Herman & Callens, Steven & Luchters, Stanley & Temmerman, Marleen & Hamers, Françoise F., 2011. "HIV testing in Europe: Mapping policies," Health Policy, Elsevier, vol. 103(2), pages 101-110.
    13. Hrayer Aprahamian & Douglas R. Bish & Ebru K. Bish, 2019. "Optimal Risk-Based Group Testing," Management Science, INFORMS, vol. 65(9), pages 4365-4384, September.
    14. Lauren E Cipriano & Gregory S Zaric & Mark Holodniy & Eran Bendavid & Douglas K Owens & Margaret L Brandeau, 2012. "Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-14, September.
    15. Valerio Brescia & Myriam Caratù & Giacomo Scaioli, 2021. "A Community-Based Social Marketing Strategy to Prevent HIV and Fight Stigma," International Journal of Business and Management, Canadian Center of Science and Education, vol. 14(10), pages 196-196, July.
    16. Giovanni S. P. Malloy & Jeremy D. Goldhaber-Fiebert & Eva A. Enns & Margaret L. Brandeau, 2021. "Predicting the Effectiveness of Endemic Infectious Disease Control Interventions: The Impact of Mass Action versus Network Model Structure," Medical Decision Making, , vol. 41(6), pages 623-640, August.
    17. Sterck Olivier, 2013. "Why are Testing Rates so Low in Sub-Saharan Africa? Misconceptions and Strategic Behaviors," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 219-257, September.
    18. Phyllis Dako-Gyeke & Esther Boatemaa Agyapong, 2014. "Utilization of HIV Counselling and Testing Services in Urban and Rural Communities in Eastern Region of Ghana: Implications for Achieving Universal HCT Coverage," Academic Journal of Interdisciplinary Studies, Richtmann Publishing Ltd, vol. 3, July.
    19. Angotti, Nicole & Bula, Agatha & Gaydosh, Lauren & Kimchi, Eitan Zeev & Thornton, Rebecca L. & Yeatman, Sara E., 2009. "Increasing the acceptability of HIV counseling and testing with three C's: Convenience, confidentiality and credibility," Social Science & Medicine, Elsevier, vol. 68(12), pages 2263-2270, June.
    20. Roy Lothan & Noa Gutman & Dan Yamin, 2022. "Country versus pharmaceutical company interests for hepatitis C treatment," Health Care Management Science, Springer, vol. 25(4), pages 725-749, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2022:i:1:p:457-:d:1016898. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.